The Role of Chemokines in Obesity and Exercise-Induced Weight Loss

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2024 Sep 28

PMID 39334887

Authors

Wenbi He

Huan Wang

Gaoyuan Yang

Lin Zhu

Xiaoguang Liu

Affiliations

Soon will be listed here.

Abstract

Obesity is a global health crisis that is closely interrelated to many chronic diseases, such as cardiovascular disease and diabetes. This review provides an in-depth analysis of specific chemokines involved in the development of obesity, including C-C motif chemokine ligand 2 (CCL2), CCL3, CCL5, CCL7, C-X-C motif chemokine ligand 8 (CXCL8), CXCL9, CXCL10, CXCL14, and XCL1 (lymphotactin). These chemokines exacerbate the symptoms of obesity by either promoting the inflammatory response or by influencing metabolic pathways and recruiting immune cells. Additionally, the research highlights the positive effect of exercise on modulating chemokine expression in the obese state. Notably, it explores the potential effects of both aerobic exercises and combined aerobic and resistance training in lowering levels of inflammatory mediators, reducing insulin resistance, and improving metabolic health. These findings suggest new strategies for obesity intervention through the modulation of chemokine levels by exercise, providing fresh perspectives and directions for the treatment of obesity and future research.

References

Mantovani A . The chemokine system: redundancy for robust outputs. Immunol Today. 1999; 20(6):254-7. DOI: 10.1016/s0167-5699(99)01469-3. View

Damaso A, Campos R, Caranti D, de Piano A, Fisberg M, Foschini D . Aerobic plus resistance training was more effective in improving the visceral adiposity, metabolic profile and inflammatory markers than aerobic training in obese adolescents. J Sports Sci. 2014; 32(15):1435-45. DOI: 10.1080/02640414.2014.900692. View

Akhter N, Kochumon S, Hasan A, Wilson A, Nizam R, Madhoun A . IFN-γ and LPS Induce Synergistic Expression of CCL2 in Monocytic Cells via H3K27 Acetylation. J Inflamm Res. 2022; 15:4291-4302. PMC: 9343018. DOI: 10.2147/JIR.S368352. View

Effting P, Thirupathi A, Muller A, Pereira B, Sepa-Kishi D, Marqueze L . Resistance Exercise Training Improves Metabolic and Inflammatory Control in Adipose and Muscle Tissues in Mice Fed a High-Fat Diet. Nutrients. 2022; 14(11). PMC: 9182921. DOI: 10.3390/nu14112179. View

Said M, Abdelmoneem M, Almaqhawi A, Hamid Kotob A, Alibrahim M, Bougmiza I . Multidisciplinary approach to obesity: Aerobic or resistance physical exercise?. J Exerc Sci Fit. 2019; 16(3):118-123. PMC: 6323181. DOI: 10.1016/j.jesf.2018.11.001. View

Felix-Soriano E, Sainz N, Gil-Iturbe E, Castilla-Madrigal R, Celay J, Fernandez-Galilea M . Differential remodeling of subcutaneous white and interscapular brown adipose tissue by long-term exercise training in aged obese female mice. J Physiol Biochem. 2023; 79(2):451-465. PMC: 10300187. DOI: 10.1007/s13105-023-00964-2. View

Fukuda Y, Asaoka T, Eguchi H, Yokota Y, Kubo M, Kinoshita M . Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma. Cancer Sci. 2019; 111(2):323-333. PMC: 7004525. DOI: 10.1111/cas.14267. View

Dehlin M, Jacobsson L, Roddy E . Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020; 16(7):380-390. DOI: 10.1038/s41584-020-0441-1. View

Larsson S, Burgess S, Michaelsson K . Genetic association between adiposity and gout: a Mendelian randomization study. Rheumatology (Oxford). 2018; 57(12):2145-2148. PMC: 6697177. DOI: 10.1093/rheumatology/key229. View

10.

Gil A, Aguilera C, Gil-Campos M, Canete R . Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr. 2007; 98 Suppl 1:S121-6. DOI: 10.1017/S0007114507838050. View

11.

Cui S, Qiao L, Yu S, Men L, Li Y, Li F . The antagonist of CXCR1 and CXCR2 protects mice from metabolic diseases through modulating inflammation. Am J Physiol Endocrinol Metab. 2019; 317(6):E1205-E1217. DOI: 10.1152/ajpendo.00117.2019. View

12.

Cereijo R, Quesada-Lopez T, Gavalda-Navarro A, Tarasco J, Pellitero S, Reyes M . The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans. Int J Obes (Lond). 2021; 45(3):706-710. DOI: 10.1038/s41366-020-00732-y. View

13.

Rohm T, Meier D, Olefsky J, Donath M . Inflammation in obesity, diabetes, and related disorders. Immunity. 2022; 55(1):31-55. PMC: 8773457. DOI: 10.1016/j.immuni.2021.12.013. View

14.

Korkmaz H, Ozkan B . Impact of Obesity on Bone Metabolism in Children. J Pediatr Endocrinol Metab. 2022; 35(5):557-565. DOI: 10.1515/jpem-2021-0714. View

15.

Kim D, Kim J, Yoon J, Ghim J, Yea K, Song P . CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice. Diabetologia. 2014; 57(7):1456-65. DOI: 10.1007/s00125-014-3237-5. View

16.

Berge J, Hjelmesaeth J, Hertel J, Gjevestad E, Smastuen M, Johnson L . Effect of Aerobic Exercise Intensity on Energy Expenditure and Weight Loss in Severe Obesity-A Randomized Controlled Trial. Obesity (Silver Spring). 2021; 29(2):359-369. PMC: 7898283. DOI: 10.1002/oby.23078. View

17.

Arner E, Mejhert N, Kulyte A, Balwierz P, Pachkov M, Cormont M . Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes. 2012; 61(8):1986-93. PMC: 3402332. DOI: 10.2337/db11-1508. View

18.

Wasmuth H, Tacke F, Trautwein C . Chemokines in liver inflammation and fibrosis. Semin Liver Dis. 2010; 30(3):215-25. DOI: 10.1055/s-0030-1255351. View

19.

Kraemer W, Ratamess N . Fundamentals of resistance training: progression and exercise prescription. Med Sci Sports Exerc. 2004; 36(4):674-88. DOI: 10.1249/01.mss.0000121945.36635.61. View

20.

Kitade H, Sawamoto K, Nagashimada M, Inoue H, Yamamoto Y, Sai Y . CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes. 2012; 61(7):1680-90. PMC: 3379680. DOI: 10.2337/db11-1506. View